# A Clinical Safety Study of AT-100 (rhSP-D) in Preterm Neonates at High Risk for Bronchopulmonary Dysplasia (BPD)

> **NCT04662151** · PHASE1 · COMPLETED · sponsor: **Airway Therapeutics, Inc.** · enrollment: 37 (actual)

## Conditions studied

- Bronchopulmonary Dysplasia

## Interventions

- **BIOLOGICAL:** AT-100
- **PROCEDURE:** Air-sham

## Key facts

- **NCT ID:** NCT04662151
- **Lead sponsor:** Airway Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-01
- **Primary completion:** 2023-08-14
- **Final completion:** 2024-05-29
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2024-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04662151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04662151, "A Clinical Safety Study of AT-100 (rhSP-D) in Preterm Neonates at High Risk for Bronchopulmonary Dysplasia (BPD)". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT04662151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*